![](/img/cover-not-exists.png)
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study
Yamamoto, Yutaka, Iwata, Hiroji, Ueno, Takayuki, Taira, Naruto, Kashiwaba, Masahiro, Takahashi, Masato, Tada, Hiroshi, Tsugawa, Koichiro, Toyama, Tatsuya, Niikura, Naoki, Hara, Fumikata, Fujisawa, TomLanguage:
english
Journal:
Japanese Journal of Clinical Oncology
DOI:
10.1093/jjco/hyy097
Date:
July, 2018
File:
PDF, 303 KB
english, 2018